pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
396
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
DB-2Q
ExoFlo
Acute Respiratory Distress Syndrome
Direct Biologics LLC
0
catalysts
Preclinical
EB-07
paridiprubart [INN]
Pulmonary Fibrosis
$EDSA
Edesa Biotech, Inc.
0
catalysts
Phase 1
EG-001
Idiopathic Interstitial Pneumonia (IIP)
Shenzhen Evergreen Therapeutics Co Ltd
0
catalysts
Phase 2
← prev
page 6 of 14
next →
131
Pain
89
Neurology
1
ETD-001
Cystic Fibrosis
Enterprise Therapeutics Ltd
0
catalysts
Preclinical
ETH-42
Primary Ciliary Dyskinesia
ethris GmbH
0
catalysts
Preclinical
EVQ-218
Aspergillosis
Evoq Nano Inc
0
catalysts
Preclinical
EXP-01
Acute Respiratory Distress Syndrome
Exorphia Co Ltd
0
catalysts
Marketed
Elocon
Nasonex 24 HR Allergy (mometasone furoate)
Nasal Congestion
L. Perrigo Company
0
catalysts
Marketed
Eryped
E.E.S. (erythromycin [INN])
Acute Intestinal Amoebiasis
Carnegie Pharmaceuticals LLC
0
catalysts
Preclinical
F-528
Chronic Obstructive Pulmonary Disease (COPD)
$GYRE
GYRE THERAPEUTICS, INC.
0
catalysts
Preclinical
FN-2012
Idiopathic Pulmonary Fibrosis
Faknostics LLC
0
catalysts
Marketed
Flonase Sensimist
Flonase Sensimist (fluticasone furoate)
Perennial Allergic Rhinitis
GlaxoSmithKline LLC
0
catalysts
Phase 1
GNS-3545
Idiopathic Pulmonary Fibrosis
Genosco Inc
0
catalysts
Phase 1
GRC-39815
Chronic Obstructive Pulmonary Disease (COPD)
Glenmark Pharmaceuticals Ltd
0
catalysts
Preclinical
HL-001
Idiopathic Pulmonary Fibrosis
UBE Corp
0
catalysts
Phase 1
HNC-1058
Idiopathic Pulmonary Fibrosis
Guangzhou Henovcom Bioscience Co Ltd
0
catalysts
Phase 1
HY-1003
Emphysema
Wuhan Healthgen Biotechnology Corp
0
catalysts
Preclinical
IL-21120033
Idiopathic Pulmonary Fibrosis
iLEAD Biomedical Science Inc
0
catalysts
Phase 1
IM-3050
Solid Tumor
$IMNM
Immunome Inc.
0
catalysts
Phase 2
INNA-051
Viral Respiratory Tract Infection
ENA Respiratory Pty Ltd
0
catalysts
Phase 2
JadiCell ARDS
Acute Respiratory Distress Syndrome
Breathe Biologics Inc
0
catalysts
Phase 1
KB-407
Cystic Fibrosis
$KRYS
Krystal Biotech, Inc.
0
catalysts
Phase 1
KBLP-002
Asthma
KoBioLabs Inc
0
catalysts
Phase 1
KSP-1007
Ventilator Associated Pneumonia (VAP)
Sumitomo Pharma Co Ltd
0
catalysts
Phase 2
KT-621
Eosinophilic Asthma
$KYMR
Kymera Therapeutics, Inc.
0
catalysts
Preclinical
LGM-1506
Asthma
Lignamed LLC
0
catalysts
Preclinical
LGM-2605
Asthma
Lignamed LLC
0
catalysts
Phase 2
LTI-03
Idiopathic Pulmonary Fibrosis
$RNTX
Rein Therapeutics, Inc.
0
catalysts
Preclinical
ME-101
Neonatal Respiratory Distress Syndrome
Molecular Express Inc
0
catalysts
Phase 2
MTX-463
Idiopathic Pulmonary Fibrosis
Eli Lilly and Co
0
catalysts
